Disrupting actin-myosin-actin connectivity in airway smooth muscle as a treatment for asthma?

Proc Am Thorac Soc. 2009 May 1;6(3):295-300. doi: 10.1513/pats.200808-078RM.

Abstract

Breathing is known to functionally antagonize bronchoconstriction caused by airway muscle contraction. During breathing, tidal lung inflation generates force fluctuations that are transmitted to the contracted airway muscle. In vitro, experimental application of force fluctuations to contracted airway smooth muscle strips causes them to relengthen. Such force fluctuation-induced relengthening (FFIR) likely represents the mechanism by which breathing antagonizes bronchoconstriction. Thus, understanding the mechanisms that regulate FFIR of contracted airway muscle could suggest novel therapeutic interventions to increase FFIR, and so to enhance the beneficial effects of breathing in suppressing bronchoconstriction. Here we propose that the connectivity between actin filaments in contracting airway myocytes is a key determinant of FFIR, and suggest that disrupting actin-myosin-actin connectivity by interfering with actin polymerization or with myosin polymerization merits further evaluation as a potential novel approach for preventing prolonged bronchoconstriction in asthma.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Actin Cytoskeleton / physiology
  • Asthma / drug therapy*
  • Asthma / physiopathology
  • Bronchoconstriction / physiology
  • Humans
  • Smooth Muscle Myosins / physiology

Substances

  • Smooth Muscle Myosins